STOCK TITAN

OLAPLEX (OLPX) General Counsel cashes out shares as Henkel merger cancels options

Filing Impact
(Very High)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

OLAPLEX HOLDINGS, INC. General Counsel John C. Duffy reported dispositions tied to the company’s merger with Henkel US Operations Corporation. At the merger’s effective time, his 971,384 common shares were converted into the right to receive $2.06 per share in cash.

The filing also notes 803,173 shares underlying his restricted stock units were cancelled and converted into the same cash consideration. In addition, 170,000 stock options with exercise prices of $5.41 and $14.95 per share were cancelled for no consideration, leaving him with no reported remaining shares or options.

Positive

  • None.

Negative

  • None.
Insider Duffy John C
Role General Counsel
Type Security Shares Price Value
Disposition Company Stock Options 85,000 $0.00 --
Disposition Company Stock Options 85,000 $0.00 --
Disposition Common Stock 971,384 $2.06 $2.00M
Holdings After Transaction: Company Stock Options — 0 shares (Direct, null); Common Stock — 0 shares (Direct, null)
Footnotes (1)
  1. Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated March 26, 2026, by and among the Issuer, Henkel US Operations Corporation ("Parent"), and Margot Acquisition Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer, with the Issuer surviving the Merger as a wholly owned subsidiary of Parent (the "Merger" and, together with the other transactions contemplated by the Merger Agreement, the "Transactions"). At the effective time of the Merger (the "Effective Time"), each share of Common Stock of the Issuer (each, a "Share") issued and outstanding immediately prior to the Effective Time was converted automatically into the right to receive $2.06 per Share in cash (the "Merger Consideration"), without interest, subject to any withholding of taxes required by applicable law. At the Effective Time, each award of restricted stock units covering Shares granted under the Issuer's 2021 Equity Incentive Plan, the Issuer's Amended & Restated 2020 Omnibus Equity Incentive Plan, or any other effective equity or equity-based incentive plan sponsored by the Issuer or its affiliates (collectively, the "Company Equity Plans") (each such award, a "Company RSU Award") that was outstanding immediately prior to the Effective Time (whether vested or unvested) was, by virtue of the Merger, automatically cancelled and converted into the right to receive (without interest) an amount in cash equal to the product of (x) the aggregate number of Shares underlying such Company RSU Award, multiplied by (y) the Merger Consideration. The amount reported includes 803,173 Shares underlying the Reporting Person's Company RSU Awards, which were automatically cancelled and converted into the right to receive the Merger Consideration at the Effective Time. At the Effective Time, each option to purchase Shares granted under the Issuer's Company Equity Plans (each, a "Company Option") that was outstanding and unexercised immediately prior to the Effective Time (whether vested or unvested) was, by virtue of the Merger, automatically cancelled and converted into the right to receive (without interest) an amount in cash equal to the product of (x) the aggregate number of Shares underlying such Company Option, multiplied by (y) the excess, if any, of the Merger Consideration over the per Share exercise price of such Company Option; provided, however, that any Company Option that had a per Share exercise price that was equal to or greater than the Merger Consideration was cancelled for no consideration. (Continued from footnote 3) The Reporting Person held Company Options in two tranches: (i) 85,000 Company Options with a per Share exercise price of $14.95 and (ii) 85,000 Company Options with a per Share exercise price of $5.41. Both exercise prices exceeded the Merger Consideration of $2.06 per Share. Accordingly, all 170,000 of the Reporting Person's Company Options were cancelled for no consideration at the Effective Time.
Common shares disposed 971,384 shares Converted into right to receive $2.06 per share cash in merger
Merger consideration $2.06 per share Cash paid for each outstanding OLAPLEX common share
RSU underlying shares 803,173 shares Restricted stock units cancelled and paid in cash at $2.06
Options at $5.41 strike 85,000 options at $5.41 Cancelled for no consideration; strike exceeded $2.06 merger price
Options at $14.95 strike 85,000 options at $14.95 Cancelled for no consideration; strike exceeded $2.06 merger price
Total options cancelled 170,000 options All reporting person’s company options cancelled at effective time
Shares after transaction 0 shares Total OLAPLEX common stock held by reporting person post-merger
Agreement and Plan of Merger regulatory
"Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated March 26, 2026..."
An Agreement and Plan of Merger is a formal document where two companies agree to combine into one, outlining how the process will happen. It’s like a step-by-step plan for merging, and it matters because it shows both sides have agreed on the details before the official transition takes place.
Merger Consideration financial
"was converted automatically into the right to receive $2.06 per Share in cash (the "Merger Consideration")..."
Merger consideration is the total payment a company or buyer offers to shareholders of a target company in exchange for combining the two businesses, and can include cash, shares in the surviving company, debt assumption, or a mix of these. Investors care because the form and amount affect the deal’s value, tax consequences, immediate cash received versus future ownership, and the risk and upside of holding new shares — similar to choosing between cash now or stock that could grow later.
restricted stock units financial
"each award of restricted stock units covering Shares granted under the Issuer's 2021 Equity Incentive Plan..."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Company RSU Award financial
"each such award, a "Company RSU Award") that was outstanding immediately prior to the Effective Time..."
Company Option financial
"each option to purchase Shares granted under the Issuer's Company Equity Plans (each, a "Company Option")..."
Equity Incentive Plan financial
"granted under the Issuer's 2021 Equity Incentive Plan, the Issuer's Amended & Restated 2020 Omnibus Equity Incentive Plan..."
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did OLAPLEX (OLPX) report for John C. Duffy?

OLAPLEX reported that General Counsel John C. Duffy disposed of 971,384 common shares in connection with the company’s merger. Those shares were automatically converted into the right to receive $2.06 per share in cash at the merger’s effective time.

How were John C. Duffy’s OLAPLEX (OLPX) restricted stock units treated in the merger?

Duffy’s restricted stock units covering 803,173 OLAPLEX shares were automatically cancelled and converted into a cash payment. The cash amount equals the number of underlying shares multiplied by the merger consideration of $2.06 per share, with no interest, subject to tax withholding.

What happened to John C. Duffy’s OLAPLEX (OLPX) stock options in the merger?

Duffy held 170,000 OLAPLEX stock options in two tranches with exercise prices of $5.41 and $14.95 per share. Because both exceeded the $2.06 merger consideration, all these options were cancelled at the effective time for no consideration.

Did John C. Duffy retain any OLAPLEX (OLPX) shares or options after the merger?

According to the Form 4, Duffy’s common stock and option holdings fell to zero after the merger transactions. His shares were converted into cash rights and all 170,000 stock options were cancelled, leaving no reported remaining equity or derivative position in OLAPLEX.

What cash consideration did OLAPLEX (OLPX) shareholders receive in the Henkel merger?

Each outstanding OLAPLEX common share was automatically converted into the right to receive $2.06 in cash at the merger’s effective time. This per-share “Merger Consideration” applied to Duffy’s holdings and other shares, subject to any required tax withholding under applicable law.

How were OLAPLEX (OLPX) equity awards generally treated under the merger agreement?

Under the merger agreement, restricted stock units were cancelled and paid out in cash based on the $2.06 per-share consideration. Stock options were cancelled and paid cash only if their exercise price was below $2.06; options with higher exercise prices were cancelled for no consideration.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
X
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Duffy John C

(Last)(First)(Middle)
OLAPLEX HOLDINGS, INC.
432 PARK AVENUE SOUTH, THIRD FLOOR

(Street)
NEW YORK NEW YORK 10016

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
OLAPLEX HOLDINGS, INC. [ OLPX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
General Counsel
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/07/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/07/2026D971,384(2)D$2.06(1)0D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Company Stock Options$14.9507/07/2026D85,000(3)(4) (3)(4) (3)(4)Common Stock85,000(3)(4)0D
Company Stock Options$5.4107/07/2026D85,000(3)(4) (3)(4) (3)(4)Common Stock85,000(3)(4)0D
Explanation of Responses:
1. Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated March 26, 2026, by and among the Issuer, Henkel US Operations Corporation ("Parent"), and Margot Acquisition Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer, with the Issuer surviving the Merger as a wholly owned subsidiary of Parent (the "Merger" and, together with the other transactions contemplated by the Merger Agreement, the "Transactions"). At the effective time of the Merger (the "Effective Time"), each share of Common Stock of the Issuer (each, a "Share") issued and outstanding immediately prior to the Effective Time was converted automatically into the right to receive $2.06 per Share in cash (the "Merger Consideration"), without interest, subject to any withholding of taxes required by applicable law.
2. At the Effective Time, each award of restricted stock units covering Shares granted under the Issuer's 2021 Equity Incentive Plan, the Issuer's Amended & Restated 2020 Omnibus Equity Incentive Plan, or any other effective equity or equity-based incentive plan sponsored by the Issuer or its affiliates (collectively, the "Company Equity Plans") (each such award, a "Company RSU Award") that was outstanding immediately prior to the Effective Time (whether vested or unvested) was, by virtue of the Merger, automatically cancelled and converted into the right to receive (without interest) an amount in cash equal to the product of (x) the aggregate number of Shares underlying such Company RSU Award, multiplied by (y) the Merger Consideration. The amount reported includes 803,173 Shares underlying the Reporting Person's Company RSU Awards, which were automatically cancelled and converted into the right to receive the Merger Consideration at the Effective Time.
3. At the Effective Time, each option to purchase Shares granted under the Issuer's Company Equity Plans (each, a "Company Option") that was outstanding and unexercised immediately prior to the Effective Time (whether vested or unvested) was, by virtue of the Merger, automatically cancelled and converted into the right to receive (without interest) an amount in cash equal to the product of (x) the aggregate number of Shares underlying such Company Option, multiplied by (y) the excess, if any, of the Merger Consideration over the per Share exercise price of such Company Option; provided, however, that any Company Option that had a per Share exercise price that was equal to or greater than the Merger Consideration was cancelled for no consideration.
4. (Continued from footnote 3) The Reporting Person held Company Options in two tranches: (i) 85,000 Company Options with a per Share exercise price of $14.95 and (ii) 85,000 Company Options with a per Share exercise price of $5.41. Both exercise prices exceeded the Merger Consideration of $2.06 per Share. Accordingly, all 170,000 of the Reporting Person's Company Options were cancelled for no consideration at the Effective Time.
/s/ John Duffy07/07/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)